Calamos Advisors LLC Increases Stock Holdings in Intuitive Surgical, Inc. $ISRG

Calamos Advisors LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 11.6% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 126,302 shares of the medical equipment provider’s stock after buying an additional 13,138 shares during the quarter. Calamos Advisors LLC’s holdings in Intuitive Surgical were worth $68,634,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also made changes to their positions in the company. Aaron Wealth Advisors LLC increased its position in Intuitive Surgical by 0.8% during the 2nd quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after purchasing an additional 19 shares in the last quarter. J. W. Coons Advisors LLC grew its stake in Intuitive Surgical by 1.4% during the 1st quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock valued at $741,000 after purchasing an additional 20 shares in the last quarter. Exencial Wealth Advisors LLC increased its holdings in Intuitive Surgical by 3.1% during the 1st quarter. Exencial Wealth Advisors LLC now owns 661 shares of the medical equipment provider’s stock worth $327,000 after purchasing an additional 20 shares during the last quarter. Evergreen Capital Management LLC raised its position in shares of Intuitive Surgical by 0.5% in the 1st quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock valued at $2,124,000 after purchasing an additional 20 shares in the last quarter. Finally, Rise Advisors LLC raised its position in shares of Intuitive Surgical by 5.6% in the 1st quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock valued at $187,000 after purchasing an additional 20 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, CEO David J. Rosa sold 24,500 shares of the stock in a transaction that occurred on Friday, October 24th. The shares were sold at an average price of $547.55, for a total transaction of $13,414,975.00. Following the completion of the sale, the chief executive officer directly owned 234,256 shares of the company’s stock, valued at $128,266,872.80. This represents a 9.47% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Myriam Curet sold 105 shares of the firm’s stock in a transaction on Monday, November 10th. The stock was sold at an average price of $560.00, for a total value of $58,800.00. The disclosure for this sale is available in the SEC filing. Insiders have sold 101,683 shares of company stock valued at $53,517,192 over the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Up 0.0%

Shares of Intuitive Surgical stock opened at $572.45 on Thursday. The stock has a market capitalization of $205.21 billion, a price-to-earnings ratio of 75.72, a PEG ratio of 4.94 and a beta of 1.62. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $616.00. The business’s 50 day simple moving average is $478.64 and its 200-day simple moving average is $502.49.

Intuitive Surgical (NASDAQ:ISRG) last posted its earnings results on Tuesday, October 21st. The medical equipment provider reported $2.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.99 by $0.41. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The firm had revenue of $2.51 billion during the quarter, compared to analyst estimates of $2.41 billion. During the same period in the previous year, the business posted $1.84 EPS. Intuitive Surgical’s revenue was up 22.9% on a year-over-year basis. Sell-side analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

A number of analysts have recently weighed in on the stock. Jefferies Financial Group raised their price target on shares of Intuitive Surgical from $550.00 to $560.00 and gave the stock a “hold” rating in a research report on Wednesday, October 22nd. Evercore ISI raised their price objective on shares of Intuitive Surgical from $450.00 to $540.00 in a report on Wednesday, October 22nd. Erste Group Bank reissued a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Argus increased their price target on shares of Intuitive Surgical from $600.00 to $630.00 in a research report on Monday, October 27th. Finally, Raymond James Financial set a $603.00 price target on Intuitive Surgical and gave the stock an “outperform” rating in a research note on Wednesday, October 22nd. Two equities research analysts have rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $608.92.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.